The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and ...

New research assessing the efficacy of optical genome mapping (OGM) in a group of patients with acute leukemia has ...

The global preimplantation genetic testing market is growing steadily, valued at around US$ 598.4 million in 2026 and projected to reach US$ 1,081.9 million ...

To address these shortcomings, we introduce SymPcNSGA-Testing (Symbolic execution, Path clustering and NSGA-II Testing), a ...

Inspired by the infrared sensory organs of snakes, which allow them to detect prey in complete darkness, researchers at UNIST ...

To use this evidence, investigators typically must grow the larvae until adulthood in a laboratory setting and then identify ...

Researchers engineered the first RNA-based NAND gate in living cells using deep learning and Bayesian optimization, testing ...

In most boardrooms, the final decision still comes down to a small circle of leaders weighing a narrow set of choices. Yet the problems they face now contain thousands, sometimes millions, of possible ...

L1, EBV and mismatch repair deficiency suggests CLDN18.2 stratification must be integrated into multi-biomarker algorithms rather than used in isolation. Treatment interactions emerged: CLDN18.2-high ...

AI in genomics offers transformative opportunities by enhancing drug discovery and personalized medicine through efficient genomic data analysis. Drivers include the surge in genomic data, the focus ...

AI in life sciences presents key opportunities in drug discovery, personalized medicine, and diagnostics by leveraging vast datasets for precise, cost-effective solutions. Growth is driven by ...